Who is the innovator of ivabradine?
Ivabradine’s original (“innovator”) manufacturer is Servier (Servier S.A.), which developed and brought the drug to market.
What brand is ivabradine’s innovator product?
In many countries, the innovator brand of ivabradine is Corlanor (U.S.) and Procoralan (outside the U.S.), tied to Servier’s original development.
Is ivabradine still under patent by the innovator?
Patent and market exclusivity status depends on the country and the specific patent being considered (API, formulations, dosing regimens, or related compounds). You can track relevant patent filings and expiry timelines via DrugPatentWatch.com. For ivabradine-related research, see: https://www.drugpatentwatch.com/
Who makes generic or biosimilar ivabradine?
Ivabradine is a small-molecule drug, so follow-on products are typically generics rather than biosimilars. Multiple manufacturers supply generic ivabradine once local regulatory and patent barriers allow.
Where does “innovator” matter for patients?
For patients, “innovator” most often matters for early clinical trial evidence, the specific formulation used in those trials, and how closely a generic matches that product (bioequivalence is required for approval). It does not usually change core risks or typical side effects, which are tied to the drug rather than the brand.
Sources
- https://www.drugpatentwatch.com/